Up to now, methods to estimate the maximum sustainable yield (MSY) of fish stocks are very complex and, as a consequence, expensive. However, Dr Rainer Froese, biologist with GEOMAR | Helmholtz Centre for Ocean Research Kiel (Germany) and Dr Steven Martell, biologist with the University of British Columbia (Canada) have recently presented a new, much simpler method to estimate the MSY. This method may even affect the proposed reform of the European fisheries.
The aim is straightforward: In 1982, more than 160 countries agreed to maintain the global fish stocks at levels that can produce the maximum sustainable yield (MSY) over a long term. This agreement is part of the United Nations Convention on the Law of the Sea (UNCLOS), which came into force in 1994 and which has been ratified by Germany and all other countries of the European Union. While the USA, Australia or New Zealand started to change their fishing policies on the basis of UNCLOS years ago, reforms in the EU only started in 2012.
One basic problem in fisheries reform is the specification of a reference point for sustainable management of fish stocks. “Until now one needs a long time series quantifying the total number of fish belonging to one stock”, explains Dr Rainer Froese, fisheries scientist with GEOMAR | Helmholtz Centre for Ocean Research Kiel. For these stock evaluations, extensive and expensive research is necessary. Therefore, for many fish stocks, the MSY is still unknown. Now Dr Froese and Dr Steven Martell, biologist with the University of British Columbia in Vancouver (CA), have come up with a new, much simpler method to estimate MSY. They present it online in the international journal “Fish and Fisheries”.
“Instead of using the total number of fish in one stock we use catch data, which are available for most fish stocks”, explains Dr. Froese. As a second type of data they use an estimate of the resilience of the species. “This is basic biological knowledge. For most species, it’s available from FishBase, a global database with key information on all fish of the world”, says Dr Froese. From the relationship between catch data and resilience, the two biologists calculate the MSY.
To test their new idea, Dr Froese and Dr. Martell applied it to 148 different fish stocks from all over the world, where earlier studies had already estimated MSY with conventional methods. “We found excellent agreement between our results and those achieved with the data-hungry standard methods”, Froese emphasises.The new method to estimate MSY also has an unexpected European Union dimension. On 12 June 2012 the EU agricultural ministers, who are also in charge of European fisheries, agreed to allow continued overfishing until 2020 for fish stocks where no sustainability reference points are available. This is currently the case for the majority of the European stocks. Such justification for high catch quotas may now have disappeared. As Rainer Froese puts it: “Lack of reference points can no longer be used as an excuse for lack of management.”
Jan Steffen | EurekAlert!
Emissions from road construction could be halved using today’s technology
18.05.2020 | Schwedischer Forschungsrat - The Swedish Research Council
When every particle counts: IOW develops comprehensive guidelines for microplastic extraction from environmental samples
11.05.2020 | Leibniz-Institut für Ostseeforschung Warnemünde
In living cells, enzymes drive biochemical metabolic processes enabling reactions to take place efficiently. It is this very ability which allows them to be used as catalysts in biotechnology, for example to create chemical products such as pharmaceutics. Researchers now identified an enzyme that, when illuminated with blue light, becomes catalytically active and initiates a reaction that was previously unknown in enzymatics. The study was published in "Nature Communications".
Enzymes: they are the central drivers for biochemical metabolic processes in every living cell, enabling reactions to take place efficiently. It is this very...
Early detection of tumors is extremely important in treating cancer. A new technique developed by researchers at the University of California, Davis offers a significant advance in using magnetic resonance imaging to pick out even very small tumors from normal tissue. The work is published May 25 in the journal Nature Nanotechnology.
researchers at the University of California, Davis offers a significant advance in using magnetic resonance imaging to pick out even very small tumors from...
Microelectronics as a key technology enables numerous innovations in the field of intelligent medical technology. The Fraunhofer Institute for Biomedical Engineering IBMT coordinates the BMBF cooperative project "I-call" realizing the first electronic system for ultrasound-based, safe and interference-resistant data transmission between implants in the human body.
When microelectronic systems are used for medical applications, they have to meet high requirements in terms of biocompatibility, reliability, energy...
Thomas Heine, Professor of Theoretical Chemistry at TU Dresden, together with his team, first predicted a topological 2D polymer in 2019. Only one year later, an international team led by Italian researchers was able to synthesize these materials and experimentally prove their topological properties. For the renowned journal Nature Materials, this was the occasion to invite Thomas Heine to a News and Views article, which was published this week. Under the title "Making 2D Topological Polymers a reality" Prof. Heine describes how his theory became a reality.
Ultrathin materials are extremely interesting as building blocks for next generation nano electronic devices, as it is much easier to make circuits and other...
Scientists took a leukocyte as the blueprint and developed a microrobot that has the size, shape and moving capabilities of a white blood cell. Simulating a blood vessel in a laboratory setting, they succeeded in magnetically navigating the ball-shaped microroller through this dynamic and dense environment. The drug-delivery vehicle withstood the simulated blood flow, pushing the developments in targeted drug delivery a step further: inside the body, there is no better access route to all tissues and organs than the circulatory system. A robot that could actually travel through this finely woven web would revolutionize the minimally-invasive treatment of illnesses.
A team of scientists from the Max Planck Institute for Intelligent Systems (MPI-IS) in Stuttgart invented a tiny microrobot that resembles a white blood cell...
19.05.2020 | Event News
07.04.2020 | Event News
06.04.2020 | Event News
29.05.2020 | Materials Sciences
29.05.2020 | Materials Sciences
29.05.2020 | Power and Electrical Engineering